HIGH RESIDUAL REACTIVITY OF PLATELETS AS A PREDICTOR OF ATHEROTHROMBOSIS IN PATIENTS WITH CORONARY HEART DISEASE
Abstract: Nowadays cardiovascular pathology occupies one of the most common positions in special mortality in the world. High residual reactivity of platelet (HRRT) is a predictor of the development of atherothrombosis in patients with coronary heart disease. And also, based on a large number of studies, an associated relationship was found between age, chronic kidney disease (CKD), CYP2C19 genetic polymorphism and HRRT, which leads to the development of atherothrombotic events in patients with coronary heart disease (CHD).
Purpose of the study: To analyze sources of literature on issues related to high residual reactivity of platelets, as well as to identify the effect of high residual reactivity of platelets (HRRT) on the development of ischemic events in patients with coronary artery disease and the presence of a correlation between HRRT and various factors, such as age, chronic renal failure. and genetic polymorphism CYP2C19.
Search strategy. The search for sources was carried out in such databases as PubMed, Scopus, Web of Science, Medline, Cochrane Library. The search depth was 15 years from 2008 to 2022. 14 literature sources contain important conceptual information on this topic. Inclusion criteria: literature reviews, original articles; publications in open access and with full text in English and Russian languages. Exclusion criteria: publications of low methodological quality, conference proceedings. In total, the literature review included 60 full-text articles, which were critically evaluated.
Literature selection algorithm → Studying manuals, monographs on the topic of high residual reactivity of platelets in patients with coronary heart disease → Studying articles from journals, scientific collections, dissertations → Systematization and analysis of material on this topic → Writing an article.
Results and conclusions: HERT is a risk factor and predictor of atherothrombosis in patients with acute coronary syndrome or coronary artery disease after stenting, receiving acetylsalicylic acid and clopidogrel, and is also an indicator for modifying antiplatelet therapy to a more effective one to improve the prognosis of patients with coronary artery disease.
Number of Views: 123
Category of articles:
Reviews
Bibliography link
Zhangelova Sh.B., Nurmukhammad F.N., Nurdinov N. High residual reactivity of platelets as a predictor of atherothrombosis in patients with coronary heart disease // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 3, pp. 185-195. DOI 10.34689/SH.2023.25.3.025Related publications:
HEMODYNAMICALLY SIGNIFICANT PATENT DUCT ARTERIUS IN PREMATURE NEWBORN CHILDREN. LITERATURE REVIEW
RADIOIODINE-RESISTANT DIFFERENTIATED THYROID CANCER: CLINICOPATHOLOGICAL CHARACTERISTICS, MOLECULAR GENETIC ALTERATIONS. REVIEW.
INTERMITTENT BLADDER CATHETERIZATION AS THE “GOLD STANDARD” FOR THE TREATMENT OF NEUROGENIC BLADDER IN PERSONS WITH SPINAL CORD INJURY
IMPACT OF ARUBA TRIAL ON CURRENT PRACTICE: INTERVENTIONAL TREATMENT AND STROKE RATES IN UNRUPTURED BRAIN ARTERIOVENOUS MALFORMATIONS IN THE POST-ARUBA ERA
SMALL AIRWAY DISEASE IS A PREDICTOR FOR EARLY DIAGNOSTIC OF COPD